Skip to content
Late-StageResearch compoundModerate evidence

Vinpocetine

Brain circulation booster, a prescription medicine in Europe (Cavinton); its effect on memory is not convincing.

NootropicNeuroprotectionNeuroprotectionVasodilationnoo.affects.neuroprotectionnoo.affects.vasodilationnoo.affects.anti-inflammatorynoo.affects.memory

Pharmacology

ClassNeuroprotection · Vasodilation
Primary targetPDE1 phosphodiesterase inhibition
Targets4 receptor targets
Half-lifeAbout 1-2 hours (short; typically dosed several times a day)
OnsetTaken with meals during the day; absorption improves with food
EvidenceModerate evidence
Affected systemsnoo.affects.neuroprotectionnoo.affects.vasodilationnoo.affects.anti-inflammatorynoo.affects.memory

Contents

DETAILED OVERVIEW

What is Vinpocetine?

Vinpocetine is a brain-circulation medicine made from vincamine, an alkaloid of the lesser periwinkle. The Hungarian company Gedeon Richter developed it under the name Cavinton; in Hungary and many European and Asian countries (for example Japan and Russia) it is a prescription medicine. In the United States it is not approved as a drug, and in 2019 the American drug regulator (FDA) stated that it cannot be a dietary supplement ingredient either and warned of a risk to the fetus.

It blocks an enzyme, which relaxes the walls of brain vessels: the vessels widen, and blood flow and oxygen supply improve. Its effect on memory has been studied in age-related hardening of the arteries, but the evidence is not convincing. It can cause facial flushing, nausea, dizziness, headache and a drop in blood pressure; because it keeps platelets from clumping it could in theory increase the tendency to bleed, and together with blood thinners it means a bleeding risk. It should be avoided in pregnancy and breastfeeding because of the risk to the fetus.

Mechanism

PDE1 inhibitor + sodium-channel blocker

Half-life

About 1-2 hours (short)

Legal status

EU/JP prescription, US: not FDA-approved

Receptor profile

  • PDE1 phosphodiesteraseStrong
  • Voltage-gated sodium channelsModerate
  • IKK-β / NF-κB inflammatory pathwayModerate
  • Red blood cell deformabilityModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Facial flushing, especially after dosing
  • Nausea and other gastrointestinal upset
  • Dizziness and headache
  • Transient drop in blood pressure (mild hypotension)
  • Sleep disturbance or dry mouth in some users
  • Theoretically increased bleeding tendency from its antiplatelet effect

Contraindications · 4

  • Pregnancy and breastfeeding: the FDA warned specifically about fetal risk in 2019; avoid
  • Bleeding disorders or anticoagulant / antiplatelet therapy (increased bleeding risk)
  • Avoid in the days before scheduled surgery due to bleeding risk
  • Marked hypotension, as it may lower blood pressure further

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Vinpocetine (a Hungarian-developed compound known as Cavinton) is used to support cerebral circulation and nerve protection: it boosts blood flow and oxygen delivery to the brain and may help red blood cells move more smoothly through small vessels. It's also credited with nerve-protective and anti-inflammatory properties, and its memory-support effect has mainly been studied in older adults with circulation-related cognitive issues, though the overall scientific evidence for this remains inconclusive.

Telegram

Have a question about Vinpocetine?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC22H26N2O2
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.